GNCA 10:09 Genocea price target raised to $12 from $9 at Piper Jaffray Piper Jaffray analyst Edwrd Tenthoff raised Genocea's price target to $12 from $9 following the release of positive data from the on-going Phase IIb bridging study of GEN-003. The analyst has an Overweight rating on shares.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.